Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $45,613 | 1,383 | 99.7% |
| Gift | $100.00 | 1 | 0.2% |
| Education | $42.81 | 5 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $6,121 | 156 | $0 (2024) |
| Novo Nordisk Inc | $5,326 | 164 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $4,091 | 130 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $3,627 | 181 | $0 (2024) |
| Amgen Inc. | $3,090 | 66 | $0 (2024) |
| Intra-Sana Laboratories | $2,638 | 62 | $0 (2024) |
| Gilead Sciences, Inc. | $2,548 | 59 | $0 (2024) |
| Lilly USA, LLC | $2,084 | 72 | $0 (2024) |
| ABBVIE INC. | $1,469 | 32 | $0 (2023) |
| Allergan, Inc. | $1,306 | 41 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,331 | 186 | AstraZeneca Pharmaceuticals LP ($1,286) |
| 2023 | $6,611 | 182 | Intra-Sana Laboratories ($1,439) |
| 2022 | $5,541 | 156 | Boehringer Ingelheim Pharmaceuticals, Inc. ($1,049) |
| 2021 | $5,550 | 155 | Novo Nordisk Inc ($869.42) |
| 2020 | $3,485 | 124 | Boehringer Ingelheim Pharmaceuticals, Inc. ($636.41) |
| 2019 | $7,096 | 187 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($957.83) |
| 2018 | $6,179 | 193 | Novo Nordisk Inc ($1,021) |
| 2017 | $5,963 | 206 | Novo Nordisk Inc ($884.21) |
All Payment Transactions
1,389 individual payment records from CMS Open Payments — Page 1 of 56
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: HIV | ||||||
| 12/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.28 | General |
| 12/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.61 | General |
| Category: DIABETES | ||||||
| 12/17/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: GALLSTONES | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: Respiratory | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Gastroenterology | ||||||
| 12/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $32.82 | General |
| Category: DIABETES | ||||||
| 12/09/2024 | Azurity Pharmaceuticals, Inc. | EDARBI (Drug) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $3.46 | General |
| Category: GALLSTONES | ||||||
| 11/27/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $4.58 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $32.45 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: DIABETES | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Endocrinology | ||||||
| 11/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.85 | General |
| Category: DIABETES | ||||||
| 11/12/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: GALLSTONES | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $125.01 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Gastroenterology | ||||||
| 11/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $26.53 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.31 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 698 | 933 | $68,954 | $40,514 |
| 2022 | 17 | 674 | 846 | $70,516 | $42,945 |
| 2021 | 13 | 593 | 822 | $87,288 | $50,096 |
| 2020 | 10 | 444 | 609 | $63,390 | $29,493 |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 67 | 129 | $22,710 | $13,208 | 58.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 67 | 135 | $17,037 | $9,121 | 53.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 39 | 39 | $7,097 | $5,685 | 80.1% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 51 | 51 | $4,236 | $2,510 | 59.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 32 | 45 | $3,599 | $2,124 | 59.0% |
| 92557 | Comprehensive hearing and speech recognition test | Office | 2023 | 45 | 45 | $2,347 | $1,485 | 63.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 72 | 125 | $1,875 | $1,050 | 56.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 44 | 44 | $1,126 | $928.84 | 82.5% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 42 | 42 | $1,096 | $886.62 | 80.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 11 | 12 | $1,501 | $818.00 | 54.5% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 22 | 22 | $806.52 | $644.82 | 80.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 54 | 56 | $1,144 | $612.72 | 53.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 51 | 51 | $799.17 | $522.24 | 65.3% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 12 | 14 | $513.24 | $404.88 | 78.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 55 | 75 | $1,875 | $255.75 | 13.6% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 17 | 24 | $840.00 | $135.84 | 16.2% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 17 | 24 | $352.00 | $121.92 | 34.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 59 | 81 | $14,138 | $8,947 | 63.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 62 | 126 | $15,586 | $8,921 | 57.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 56 | 96 | $12,335 | $6,498 | 52.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 39 | 39 | $7,046 | $5,869 | 83.3% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2022 | 48 | 49 | $4,419 | $2,551 | 57.7% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 17 | 18 | $3,241 | $1,920 | 59.3% |
| 92557 | Comprehensive hearing and speech recognition test | Office | 2022 | 50 | 51 | $2,683 | $1,780 | 66.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $2,577 | $1,551 | 60.2% |
About Ricardo Issa
Ricardo Issa is a Internal Medicine healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922041524.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ricardo Issa has received a total of $45,756 in payments from pharmaceutical and medical device companies, with $5,331 received in 2024. These payments were reported across 1,389 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($45,613).
As a Medicare-enrolled provider, Issa has provided services to 2,409 Medicare beneficiaries, totaling 3,210 services with total Medicare billing of $163,048. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location New York, NY
- Active Since 06/13/2006
- Last Updated 11/16/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1922041524
Products in Payments
- JARDIANCE (Drug) $6,256
- RELTONE 200 MG (Drug) $2,388
- Ozempic (Drug) $2,175
- XIFAXAN (Drug) $2,109
- FARXIGA (Drug) $1,975
- UBRELVY (Drug) $1,273
- KRYSTEXXA (Biological) $1,226
- Saxenda (Drug) $1,196
- Aimovig (Biological) $1,188
- NURTEC ODT (Drug) $1,165
- Repatha (Biological) $1,068
- Korlym (Drug) $974.17
- Movantik (Drug) $834.20
- AIRSUPRA (Drug) $817.60
- RELISTOR (Drug) $813.21
- Truvada (Drug) $766.51
- MOUNJARO (Drug) $757.24
- TRULICITY (Drug) $740.60
- Kerendia (Drug) $724.71
- Rybelsus (Drug) $679.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in New York
Dr. Stephen Saletan, M.d, M.D
Internal Medicine — Payments: $2.7M
Michael Schuster, Md, MD
Internal Medicine — Payments: $2.1M
Dr. Ziad Ali, Md Dphil, MD DPHIL
Internal Medicine — Payments: $1.7M
Dr. James Underberg, Md, MD
Internal Medicine — Payments: $1.5M
Dr. Ricky Hsu, Md, MD
Internal Medicine — Payments: $1.2M
Gail Roboz, Md, MD
Internal Medicine — Payments: $1.1M